{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:51:23Z","timestamp":1789584683517,"version":"build-2803163510"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T00:00:00Z","timestamp":1454457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1005416","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T13:57:46Z","timestamp":1454507866000},"page":"e1005416","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients"],"prefix":"10.1371","volume":"12","author":[{"given":"Roger A.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Ironside","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane L.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Zanusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Pyo Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette A.","family":"Priola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2990.2012.01265.x","article-title":"Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain","volume":"38","author":"MW Head","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1073\/pnas.93.2.744","article-title":"Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP","volume":"93","author":"B Ghetti","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12031-011-9543-1","article-title":"Variably protease-sensitive prionopathy: a novel disease of the prion protein","volume":"45","author":"P Gambetti","year":"2011","journal-title":"J Mol Neurosci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(12)70063-7","article-title":"Sporadic human prion diseases: molecular insights and diagnosis","volume":"11","author":"G Puoti","year":"2012","journal-title":"Lancet Neurol"},{"key":"ref5","first-page":"20","article-title":"Molecular pathology, classification, and diagnosis of sporadic human prion disease variants","volume":"50","author":"P Parchi","year":"2012","journal-title":"Folia Neuropathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"P Parchi","year":"1999","journal-title":"Ann Neurol"},{"issue":"Pt 6","key":"ref7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/brain\/awg125","article-title":"Molecular classification of sporadic Creutzfeldt-Jakob disease","volume":"126","author":"AF Hill","year":"2003","journal-title":"Brain"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","article-title":"Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA","volume":"124","author":"P Parchi","year":"2012","journal-title":"Acta Neuropathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410390613","article-title":"Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease","volume":"39","author":"P Parchi","year":"1996","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1093\/brain\/awq234","article-title":"Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease","volume":"133","author":"P Parchi","year":"2010","journal-title":"Brain"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"12005","DOI":"10.1073\/pnas.1004688107","article-title":"Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties","volume":"107","author":"MT Bishop","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1750-3639.2012.00572.x","article-title":"MM2-thalamic Creutzfeldt-Jakob disease: neuropathological, biochemical and transmission studies identify a distinctive prion strain","volume":"22","author":"F Moda","year":"2012","journal-title":"Brain Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1212\/WNL.54.8.1641","article-title":"Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene","volume":"54","author":"JJ Hauw","year":"2000","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.1439789","article-title":"Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism","volume":"258","author":"LG Goldfarb","year":"1992","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/352340a0","article-title":"Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease","volume":"352","author":"MS Palmer","year":"1991","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ana.20127","article-title":"Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991\u20132002","volume":"55","author":"MW Head","year":"2004","journal-title":"Ann Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1034\/j.1600-0404.2003.00199.x","article-title":"The normal population distribution of PRNP codon 129 polymorphism","volume":"108","author":"MH Nurmi","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s004390050204","article-title":"Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene","volume":"98","author":"O Windl","year":"1996","journal-title":"Hum Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0140-6736(03)13867-6","article-title":"Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK","volume":"362","author":"JP Brandel","year":"2003","journal-title":"Lancet"},{"key":"ref20","article-title":"Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years","author":"P Rudge","year":"2015","journal-title":"Brain"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1002242","DOI":"10.1371\/journal.ppat.1002242","article-title":"Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate","volume":"7","author":"C Kim","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1093\/brain\/awp196","article-title":"Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics","volume":"132","author":"I Cali","year":"2009","journal-title":"Brain"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/2051-5960-1-74","article-title":"Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M\/V and type 2 abnormal prion protein","volume":"1","author":"A Kobayashi","year":"2013","journal-title":"Acta Neuropathol Comm"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nm0597-521","article-title":"Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt-Jakob disease patients","volume":"3","author":"MC Silvestrini","year":"1997","journal-title":"Nat Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archneur.64.4.595","article-title":"Novel prion protein conformation and glycotype in Creutzfeldt-Jakob disease","volume":"64","author":"G Zanusso","year":"2007","journal-title":"Arch Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0092-8674(90)90134-Z","article-title":"Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication","volume":"63","author":"SB Prusiner","year":"1990","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1099\/vir.0.80525-0","article-title":"Polymorphisms at codons 108 and 189 in murine PrP play distinct roles in the control of scrapie incubation time","volume":"86","author":"RM Barron","year":"2005","journal-title":"J Gen Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/pmic.201000104","article-title":"Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations","volume":"10","author":"RA Moore","year":"2010","journal-title":"Proteomics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1002\/pmic.201100253","article-title":"Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure","volume":"11","author":"RA Moore","year":"2011","journal-title":"Proteomics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1002\/rcm.3317","article-title":"Absolute and relative quantification of sheep brain prion protein (PrP) allelic variants by matrix-assisted laser desorption\/ionisation time-of-flight mass spectrometry","volume":"21","author":"N Morel","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1021\/ac0498563","article-title":"A model for random sampling and estimation of relative protein abundance in shotgun proteomics","volume":"76","author":"H Liu","year":"2004","journal-title":"Anal Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1586\/epr.09.69","article-title":"Role of spectral counting in quantitative proteomics","volume":"7","author":"DH Lundgren","year":"2010","journal-title":"Expert Rev Proteomics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1750-3639.2008.00187.x","article-title":"Inter-laboratory assessment of PrPSc typing in creutzfeldt-jakob disease: a Western blot study within the NeuroPrion Consortium","volume":"19","author":"P Parchi","year":"2009","journal-title":"Brain Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2990.1997.tb01182.x","article-title":"Prion protein immunocytochemistry\u2014UK five centre consensus report","volume":"23","author":"JE Bell","year":"1997","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1128\/JVI.69.12.7754-7758.1995","article-title":"A single hamster amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells","volume":"69","author":"SA Priola","year":"1995","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2204","article-title":"In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc","volume":"213","author":"M Jones","year":"2007","journal-title":"J Pathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/WNR.0b013e328318edfa","article-title":"Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay","volume":"19","author":"M Jones","year":"2008","journal-title":"Neuroreport"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1093\/emboj\/18.23.6855","article-title":"A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy","volume":"18","author":"JC Manson","year":"1999","journal-title":"EMBO J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1099\/vir.0.039008-0","article-title":"Significant differences in incubation times in sheep infected with bovine spongiform encephalopathy result from variation at codon 141 in the PRNP gene","volume":"93","author":"BC Tan","year":"2012","journal-title":"J Gen Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1212\/WNL.47.3.734","article-title":"Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease(PrP-P102L mutation)","volume":"47","author":"P Barbanti","year":"1996","journal-title":"Neurology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-015-1447-7","article-title":"The influence of PRNP polymorphisms on human prion disease susceptibility: an update","volume":"130","author":"A Kobayashi","year":"2015","journal-title":"Acta Neuropathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"31390","DOI":"10.1074\/jbc.M401754200","article-title":"Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt-Jakob disease","volume":"279","author":"A Tahiri-Alaoui","year":"2004","journal-title":"J Biol Chem"},{"key":"ref43","first-page":"2443","article-title":"Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation","volume":"87","author":"PA Lewis","year":"2006","journal-title":"J GenVirol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.febslet.2005.03.075","article-title":"The presence of valine at residue 129 in human prion protein accelerates amyloid formation","volume":"579","author":"I Baskakov","year":"2005","journal-title":"FEBS Lett"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"28515","DOI":"10.1074\/jbc.M313762200","article-title":"The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC","volume":"279","author":"LL Hosszu","year":"2004","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"29671","DOI":"10.1074\/jbc.C110.158303","article-title":"Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease","volume":"285","author":"MI Apostol","year":"2010","journal-title":"J Biol Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1440-1789.2008.00973.x","article-title":"A traceback phenomenon can reveal the origin of prion infection","volume":"29","author":"A Kobayashi","year":"2009","journal-title":"Neuropathology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1128\/JVI.03183-14","article-title":"Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?","volume":"89","author":"A Kobayashi","year":"2015","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nmeth1066","article-title":"Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein","volume":"4","author":"R Atarashi","year":"2007","journal-title":"Nat Methods"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","article-title":"Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay","volume":"358","author":"JD Wadsworth","year":"2001","journal-title":"Lancet"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1515\/BC.2006.013","article-title":"Detection of prion particles in samples of BSE and scrapie by fluorescence correlation spectroscopy without proteinase K digestion","volume":"387","author":"E Birkmann","year":"2006","journal-title":"Biol Chem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1074\/mcp.M400215-MCP200","article-title":"A Heuristic method for assigning a false-discovery rate for protein identifications from Mascot database search results","volume":"4","author":"DB Weatherly","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1074\/mcp.M500084-MCP200","article-title":"Comparison of label-free methods for quantifying human proteins by shotgun proteomics","volume":"4","author":"WM Old","year":"2005","journal-title":"Mol Cell Proteomics"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1005496","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T00:00:00Z","timestamp":1457395200000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1005416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T18:35:32Z","timestamp":1600108532000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1005416"}},"subtitle":[],"editor":[{"given":"Jason","family":"Bartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,3]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1005416","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,3]]}}}